Development and regulation of monoclonal antibody products: Challenges and opportunities

Author： Weinberg Wendy   Frazier-Jessen Michelle   Wu Wen   Weir Andrea   Hartsough Melanie   Keegan Patricia   Fuchs Chana  

Publisher： Springer Publishing Company

ISSN： 0167-7659

Source： Cancer and Metastasis Reviews, Vol.24, Iss.4, 2005-12, pp. : 569-584

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging “early myeloma“

By Hillengass Jens  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1355-1363

Informa Healthcare

Access to resources Recommend Favorite

Development of a 124I-labeled version of the anti-PSMA monoclonal antibody capromab for immunoPET staging of prostate cancer: Aspects of labeling chemistry and biodistribution

By          

International Journal of Oncology, Vol. 44, Iss. 6, 2014-01 ,pp. : 1998-2008

Spandidos Publications

Access to resources Recommend Favorite

Monoclonal Antibody-Based Targeted Therapy in Breast Cancer

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 2, 2005-03 ,pp. : 99-106

Bentham Science Publishers

Access to resources Recommend Favorite

Trends in Malignant Glioma Monoclonal Antibody Therapy

By  

Current Cancer Therapy Reviews, Vol. 11, Iss. 2, 2015-06 ,pp. : 102-118

Bentham Science Publishers

Access to resources Recommend Favorite

Immunostaining of Human Melanomas by a Monoclonal Antibody to B700 Mouse Melanoma Antigen

By Xu X.   Azumi N.   Skelton H.G.   Hearing V.J.   Gersten D.M.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 168-173

Elsevier

Access to resources Recommend Favorite